Загрузка...
Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study
OBJECTIVE: Sofosbuvir/ledipasvir (SOF/LED) is recommended for treatment of genotypes 1, 4, 5 and 6. Despite some preliminary data from the ELECTRON-2 trial regarding use of SOF/LED combination in chronic hepatitis C genotype 3, there are no guidelines recommending this combination in such patients....
Сохранить в:
| Опубликовано в: : | J Clin Exp Hepatol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7953013/ https://ncbi.nlm.nih.gov/pubmed/33746448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.06.011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|